Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis
- Alfonso Quintás-Cardama
- , Hagop M. Kantarjian
- , Taghi Manshouri
- , Deborah Thomas
- , Jorge Cortes
- , Farhad Ravandi
- , Guillermo Garcia-Manero
- , Alessandra Ferrajoli
- , Carlos Bueso-Ramos
- , Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review
161
Link opens in a new tab
Scopus
citations